
Biomedicines | Interview with One of Highly Cited Paper Authors—Dr. Dimitrios Papageorgiou
Dr. Dimitrios Papageorgiou is one of the authors of the highly cited paper entitled “Tubal Ectopic Pregnancy: From Diagnosis to Treatment” published in Biomedicines (ISSN: 2227-9059).
Dr. Dimitrios Papageorgiou is a Consultant Gynecologist at the Department of Gynecology of the Naval and Veterans Hospital of Athens, Greece. His clinical and academic work focuses on gynecology, gynecologic surgery, minimally invasive and robotic techniques, gynecologic oncology, and reproductive surgery. He has always believed that research should remain close to the real questions that arise in daily clinical practice. For him, medicine is not only about diagnosis and treatment; it is also about understanding the fear, uncertainty, and vulnerability that patients experience when facing a serious condition. This is particularly true in women’s health, where clinical decisions often affect not only physical safety but also fertility, identity, emotional well-being, and future life plans.
1. Congratulations on your published paper! Could you briefly describe the main research content of this paper, as well as its key innovative highlights?
Thank you very much. Our paper, entitled “Tubal Ectopic Pregnancy: From Diagnosis to Treatment”, is a narrative review that summarizes the current knowledge on tubal ectopic pregnancy, from epidemiology and risk factors to diagnosis, management, and future directions.
Tubal ectopic pregnancy is one of the most important emergencies in early pregnancy. It may begin with symptoms that appear subtle, such as pelvic pain or vaginal bleeding, but it can rapidly progress to tubal rupture, severe intra-abdominal bleeding, and a life-threatening situation. Therefore, early recognition is essential.
The key strength of this paper is that it brings together the full clinical pathway of tubal ectopic pregnancy in a practical and comprehensive way. We discuss risk factors, pathophysiology, clinical presentation, serial β-hCG assessment, transvaginal ultrasound, diagnostic laparoscopy, medical treatment with methotrexate, surgical management, expectant management, and emerging research directions.
A particularly important aspect of the review is its emphasis on individualized care. Tubal ectopic pregnancy is not only a biological event; it is also a deeply emotional experience for many women. The clinician must protect the patient’s life, preserve fertility whenever possible, and at the same time acknowledge the psychological burden of losing a pregnancy and facing uncertainty about the future.
2. Can you tell us a little bit about yourself and your current research?
I am primarily a clinician, and this strongly shapes my research interests. The questions that motivate me usually come from real situations in everyday practice: a difficult diagnosis, a complex surgical decision, or a patient whose outcome makes us reflect on how care can be improved.
My work is broadly focused on gynecologic surgery, gynecologic oncology, minimally invasive and robotic surgery, fertility preservation, and reproductive surgery. I am particularly interested in research that connects clinical decision-making with outcomes that truly matter to patients: safety, recovery, fertility, quality of life, and long-term well-being.
In gynecology, we often meet women at moments of great vulnerability. A diagnosis may arrive suddenly, during a hoped-for pregnancy, after months of infertility treatment, or in the context of cancer or major surgery. For this reason, I believe that research in women’s health should not be detached from the human experience. Good research should help us make better decisions, but it should also remind us why those decisions matter.
My current academic work continues to focus on clinically relevant questions in gynecologic care, including surgical outcomes, minimally invasive innovation, fertility-related conditions, and the improvement of patient-centered management.
3. Would you mind sharing what inspired your research?
The inspiration behind this paper came from the clinical reality of ectopic pregnancy. For an obstetrician–gynecologist, ectopic pregnancy is a condition that leaves a strong impression. It can transform a positive pregnancy test, which is often associated with hope, into a moment of fear, urgency, and emotional distress.
What is particularly difficult is that the woman may be physically stable at first, but the situation can change quickly. At the same time, the physician must make decisions that are medically urgent but emotionally complex. We are often treating not only a potentially life-threatening condition, but also the loss of a pregnancy and the anxiety about future fertility.
This dual dimension inspired us to prepare a review that would be clinically useful but also respectful of the patient’s experience. We wanted to provide a structured overview that could help clinicians diagnose earlier, choose treatment more appropriately, and communicate with patients more sensitively.
For me, ectopic pregnancy is a reminder that in medicine, speed and empathy must coexist. We must act quickly when needed, but we must never forget that behind every emergency there is a woman who is frightened, disappointed, and in need of clear guidance and compassionate care.
4. What was the biggest challenge you faced while writing this paper, and how did you overcome it?
The biggest challenge was to present a very broad and clinically complex topic in a way that remained clear, balanced, and useful for daily practice. Tubal ectopic pregnancy involves many dimensions: epidemiology, risk factors, pathophysiology, diagnostic algorithms, ultrasound findings, β-hCG interpretation, methotrexate protocols, surgical decision-making, expectant management, fertility outcomes, and future research.
Another challenge was to maintain the right tone. Ectopic pregnancy is not simply a technical diagnosis. It is a condition that may involve emergency surgery, loss of reproductive tissue, fear of bleeding, loss of pregnancy, and concern about future conception. We wanted the review to be scientifically accurate, but not emotionally indifferent.
We overcame this by organizing the manuscript around the clinical pathway of the patient. We moved from risk identification to diagnosis, then to treatment selection and future perspectives. This structure allowed us to keep the review practical while preserving the complexity of the condition.
In writing this paper, I tried to keep in mind the patient sitting in front of the clinician: a woman who needs not only correct information, but also reassurance, honesty, and a treatment plan that respects both her safety and her future hopes.
5. How did feedback during your research influence your direction?
Feedback is essential in research because it helps us see the manuscript from perspectives beyond our own. During the development of this paper, discussion within the team helped refine the structure, improve the clinical flow, and ensure that the review remained relevant to clinicians managing ectopic pregnancy in real practice.
One important influence of feedback was the need to balance detail with clarity. Ectopic pregnancy is a topic with many diagnostic and therapeutic nuances. However, a review should not overwhelm the reader; it should help the reader make sense of the evidence. Feedback helped us emphasize the most clinically meaningful points and present them in a more accessible way.
It also reinforced the importance of including the patient-centered dimension. In conditions such as ectopic pregnancy, clinical success cannot be measured only by resolution of the disease. It also includes how safely the patient is treated, whether fertility is preserved when possible, whether follow-up is adequate, and whether the woman feels supported during a difficult experience.
Scientific feedback improves the manuscript, but clinical feedback reminds us of the purpose of the manuscript: to improve care.
6. What role did you play in your research team, and how did teamwork affect the paper’s outcome?
My role involved conceptualizing the manuscript, shaping its clinical direction, contributing to the writing, and ensuring that the paper remained focused on practical decision-making in tubal ectopic pregnancy. Because my approach to research is strongly influenced by clinical practice, I wanted the review to be useful not only academically, but also at the bedside and in the emergency setting.
Teamwork was very important. Each member contributed to the development, refinement, and scientific balance of the paper. A good review requires more than collecting references; it requires judgment, structure, and the ability to interpret evidence in a way that serves clinical practice.
The collaborative process helped us produce a manuscript that was broader, clearer, and more balanced than it would have been as an individual effort. In medicine, teamwork is not only important in research; it is also central to patient care. The management of ectopic pregnancy often involves obstetricians and gynecologists, emergency physicians, radiologists, anesthesiologists, nurses, and fertility specialists. In that sense, the collaborative nature of the manuscript reflects the multidisciplinary reality of the condition itself.
7. Why did you choose the Biomedicines journal as a platform for publishing your work, and how was your experience?
We chose Biomedicines because it is an international open access journal with broad biomedical visibility and a readership that includes both clinicians and researchers. Tubal ectopic pregnancy is a topic that crosses several fields: obstetrics, gynecology, reproductive medicine, emergency care, imaging, surgery, and translational research. Therefore, it was important for us to publish in a journal that could reach a wide scientific audience.
The open access format was also important. Ectopic pregnancy is a global clinical issue, and access to updated medical information should not be limited. When a paper deals with a potentially life-threatening condition, wider accessibility can help disseminate knowledge more effectively.
My experience with Biomedicines was very positive. The editorial process was professional, and we appreciated the opportunity to present this work to an international audience. I also value the fact that the journal provides a platform for articles that combine clinical relevance with broader biomedical perspectives.
For a topic such as ectopic pregnancy, visibility matters. If the article helps even a small number of clinicians think more clearly, diagnose earlier, or communicate more compassionately with patients, then its publication has achieved something meaningful.
8. What impact do you hope your research will have, and what key innovation do you see in your paper?
I hope this paper will help clinicians approach tubal ectopic pregnancy with greater diagnostic confidence, therapeutic clarity, and human sensitivity. The most important impact would be earlier recognition, safer management, and better counseling for women experiencing this condition.
The key innovation of the paper is not the presentation of a single new intervention, but the integration of the entire clinical picture into one coherent review. Tubal ectopic pregnancy requires rapid thinking, but also individualized judgment. A stable patient with low β-hCG levels may be suitable for medical or expectant management, while another patient may require urgent surgery. The same diagnosis can therefore lead to very different clinical pathways.
I also hope the paper contributes to a more compassionate understanding of ectopic pregnancy. For clinicians, it may be a familiar emergency. For the woman, however, it may be the sudden loss of a hoped-for pregnancy, fear for her life, fear for her fertility, and an experience she will remember for years.
If our review helps clinicians combine evidence-based care with empathy, then I would consider it meaningful. In women’s health, innovation is not only technological; it is also the ability to treat the patient as a whole person.
9. What do you think the future directions for your research are?
Future research should focus on improving early diagnosis, refining patient selection for each treatment option, and developing safer, less invasive approaches. There is growing interest in novel biomarkers, improved imaging strategies, and new medical or minimally invasive surgical techniques. These areas may help us diagnose ectopic pregnancy earlier and treat it more precisely.
Another important direction is fertility preservation. Many women who experience tubal ectopic pregnancy are still planning future pregnancies. Therefore, we need more research on how different treatment strategies affect subsequent fertility, recurrence risk, psychological recovery, and long-term reproductive outcomes.
I also believe that future work should pay more attention to the emotional and psychological consequences of ectopic pregnancy. Medicine has made great progress in reducing mortality and improving surgical safety, but we must also recognize the silent burden carried by many women after such an event. Anxiety, grief, and fear of future pregnancy are real outcomes, even if they are not always measured in clinical studies.
My future research will continue to focus on clinically meaningful questions in gynecology, minimally invasive surgery, fertility, and patient-centered care. Ultimately, the goal is simple but important: to make modern gynecologic care safer, more precise, and more humane.